Skip to content

The intervention study of advance care planning for patients with hematological malignancy based on decision aids

The intervention study of advance care planning for patients with hematological malignancy based on decision aids

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070939
Enrollment
Unknown
Registered
2023-04-26
Start date
2023-04-24
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignancy

Interventions

intervention group:Cognitive intervention in advance care planning based on decision aids.

Sponsors

The First Affiliated Hospital of Medical College,Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Age = 18 years old, < 75 years old; ? Diagnosis of hematological tumors by bone marrow aspiration and knowledge of the disease: including lymphoma, leukemia, multiple myeloma, myelodysplastic syndrome, etc.; ? Length of each hospitalization = 3 days; ? Informed consent; ? Clear consciousness, no communication impairment; ? No mental cognitive impairment

Exclusion criteria

Exclusion criteria: (1) those who are too ill to communicate; (2) those who are unable to cooperate with other serious heart, liver, kidney and other important organ dysfunction; (3) those who are unable to cooperate with the study due to disease aggravation or weakness

Design outcomes

Primary

MeasureTime frame
Advance Care Planning Questionnaire;

Secondary

MeasureTime frame
Death Attitude Profile-Revised;Fear of disease progression simplified scale;

Countries

China

Contacts

Public ContactZhang Meiyun

The First Affiliated Hospital of Medical College,Zhejiang University

22118784@zju.edu.cn+86 13857185837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026